Literature DB >> 27666434

Production of a truncated recombinant HA1 for influenza A H9 subtype screening.

Wafa Tombari1, Abdeljelil Ghram2.   

Abstract

Hemagglutinin is the major component of membrane protein and plays a major role in virus entry into host cells through their receptors and it is predicted to elicit the production neutralizing antibodies. Our aim is to assess the potential of a truncated rHA1 domain, encoding residues 157-260 to detect influenza A H9 specific antibodies. The predicted characteristics of this protein revealed that it is a hydrophobic protein possessing predominant antigenicity and composed of random coils (48%) and extended strand (28%) but few α-helix (6.33%) and β-sheet (7%). A 312 pb HA1 gene was amplified and cloned in pET23b(+) vector including an C-terminal polyHis as a fusion partner, transformed and expressed in Escherichia coli cells as inclusion bodies. The truncated protein was solubilized with 8 M urea, purified by immobilized metal affinity chromatography and then detected by western blot with anti-His and H9-specific polyclonal antibodies. The test demonstrated high specificity (100%) and sensibility (98%). The immunoreactivity of the truncated rHA1 assessed revealed that only antisera against H9 yielded a specific and strong reactivity, with no cross-reactivity against negative sera. This study demonstrates that the truncated rHA1 may serve as a useful tool for rapid and easy surveillance of H9 infection.
Copyright © 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigenicity; H9 subtype; HA1 unit; Prokaryotic system; Recombinant protein; Structure prediction

Mesh:

Substances:

Year:  2016        PMID: 27666434     DOI: 10.1016/j.biologicals.2016.07.006

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  2 in total

1.  Influenza A(H9N2) Virus, Burkina Faso.

Authors:  Bianca Zecchin; Germaine Minoungou; Alice Fusaro; Sidi Moctar; Anne Ouedraogo-Kaboré; Alessia Schivo; Annalisa Salviato; Sabrina Marciano; Isabella Monne
Journal:  Emerg Infect Dis       Date:  2017-12-17       Impact factor: 6.883

Review 2.  Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa.

Authors:  Pingdwende Kader Aziz Bamogo; Christophe Brugidou; Drissa Sérémé; Fidèle Tiendrébéogo; Florencia Wendkuuni Djigma; Jacques Simpore; Séverine Lacombe
Journal:  Virol J       Date:  2019-12-30       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.